Ignite Creation Date:
2024-05-06 @ 6:22 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05646381
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2022-12-02
Brief Title:
A Multicenter Trial Assessing the Impact of Lipoproteina Lowering With Pelacarsen TQJ230 on the Progression of Calcific Aortic Valve Stenosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-02
First Submit QC Date:
December 2 2022
Study First Post Date:
2022-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL